Erratum: Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis

Yutaka Yamamoto

Hiroji Iwata

Nagoya City University, Nagoya, Japan

Shigehira Saji

Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan

Masato Takahashi

Tetsuhiro Yoshinami

Graduate School of Medicine, Osaka University, Osaka, Japan

Takayuki Ueno

Breast Oncology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

Tatsuya Toyama

Takashi Yamanaka

Toshimi Takano

Masahiro Kashiwaba

Department of Breast Surgery, Sagara Hospital Miyazaki, Miyazaki, Miyazaki, Japan

Koichiro Tsugawa

Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University Hospital, Miyamae-ku, Kawasaki, Japan

Yoshie Hasegawa

Department of Breast Surgery, Hachinohe City Hospital, Hachinohe, Aomori, Japan

Kenji Tamura

Research Center for Electronic and Optical Materials National Institute for Materials Science 1‐1 Namiki Tsukuba 305‐0044 Japan

Hiroshi Tada

Fumikata Hara

Tomomi Fujisawa

Department of Breast Oncology, Gunma Prefectural Cancer Center, Gunma, Japan

Naoki Niikura

Department of Breast Oncology, Tokai University School of Medicine, Kanagawa, Japan

Naruto Taira

Satoshi Morita

Masakazu Toi

Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo

Shinji Ohno

Sagara Hospital, Kagoshima City, Japan

Norikazu Masuda

Graduate School of Medicine, Kyoto University, Kyoto, Japan